LFST — Lifestance Health Cashflow Statement
0.000.00%
Last trade - 00:00- $2.53bn
- $2.61bn
- $1.25bn
- 80
- 60
- 77
- 84
Annual cashflow statement for Lifestance Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -38.1 | -307 | -216 | -186 | -57.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 5.75 | 287 | 233 | 145 | 122 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.753 | 2.14 | -16.9 | -33.7 | -27.4 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -8.53 | 9.42 | 52.8 | -16.9 | 107 |
| Capital Expenditures | -38.1 | -94.5 | -79.3 | -40.5 | -21.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -823 | -99.6 | -60.2 | -19.8 | 0 |
| Acquisition of Business | |||||
| Cash from Investing Activities | -861 | -194 | -139 | -60.3 | -21.6 |
| Financing Cash Flow Items | 601 | -11.2 | -20.7 | -7.86 | -8.26 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 912 | 314 | 47.3 | 47.4 | -9.95 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 42.6 | 129 | -39.4 | -29.8 | 75.7 |